CCR5 and melanoma: Interestingly, a study utilizing CCR5-Δ32 polymorphism, which results in the expression of nonfunctional CCR5, reported an association of such mutation with worse outcomes of melanoma after immunotherapy55, which suggested an anticancer role of CCR5 signaling.